{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:53:54Z","timestamp":1781715234985,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mcpiqojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.mayocpiqo.2026.100695","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T21:37:24Z","timestamp":1771623444000},"page":"100695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differences in Itch Quality Between Interleukin-31 and Thymus and Activation-Regulated Chemokine of Japanese Atopic Dermatitis"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3941-4011","authenticated-orcid":false,"given":"Yozo","family":"Ishiuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Ogawa-Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michie","family":"Katsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Dekio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Kawagoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Nobeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Budiman","family":"Kharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Ebata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9402-9387","authenticated-orcid":false,"given":"Motoki","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutoshi","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Asahina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.mayocpiqo.2026.100695_bib1","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.it.2018.10.001","article-title":"The itch\u2013scratch cycle: a neuroimmune perspective","volume":"39","author":"Mack","year":"2018","journal-title":"Trends Immunol"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2026.100695_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2340\/00015555-1402","article-title":"Questionnaires to assess chronic itch: a consensus paper of the special interest group of the International Forum on the Study of Itch","volume":"92","author":"Weisshaar","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2026.100695_bib3","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.jaci.2022.03.017","article-title":"The HOME Core outcome Set for clinical trials of atopic dermatitis","volume":"149","author":"Williams","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2026.100695_bib4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2340\/00015555-1599","article-title":"Itch characteristics in five dermatoses: non-atopic eczema, atopic dermatitis, urticaria, psoriasis and scabies","volume":"93","author":"Brenaut","year":"2013","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2026.100695_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2340\/00015555-3053","article-title":"Characteristics of pruritus in relation to self-assessed severity of atopic dermatitis","volume":"99","author":"Huet","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2026.100695_bib6","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/jdv.15743","article-title":"Comparison of pruritus and sensory qualities induced by capsaicin, histamine and cowhage","volume":"33","author":"Hawro","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2026.100695_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1365-4362.2002.01460.x","article-title":"Itch characteristics in Chinese patients with atopic dermatitis using a new questionnaire for the assessment of pruritus","volume":"41","author":"Yosipovitch","year":"2002","journal-title":"Int J Dermatol"},{"issue":"suppl 92","key":"10.1016\/j.mayocpiqo.2026.100695_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"60","author":"Hanifin","year":"1980","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2026.100695_bib9","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jaci.2018.03.018","article-title":"Nemolizumab in patients with moderate-to-severe atopic dermatitis: randomized, phase II, long-term extension study","volume":"142","author":"Kabashima","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.mayocpiqo.2026.100695_bib10","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1111\/all.14791","article-title":"Interleukin-31: the \u201citchy\u201d cytokine in inflammation and therapy","volume":"76","author":"Datsi","year":"2021","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.mayocpiqo.2026.100695_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113433","article-title":"Sensory neuronal STAT3 is critical for IL-31 receptor expression and inflammatory itch","volume":"42","author":"Takahashi","year":"2023","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2026.100695_bib12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.anai.2023.08.008","article-title":"Emerging concepts in neuropathic and neurogenic itch","volume":"131","author":"Auyeung","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.mayocpiqo.2026.100695_bib13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.5114\/ada.2021.108926","article-title":"Significance of interleukin-31 (IL-31) gene polymorphisms and IL-31 serum level in psoriasis in correlation with pruritus","volume":"38","author":"Purzycka-Bohdan","year":"2021","journal-title":"Postepy Dermatol Alergol"},{"issue":"13","key":"10.1016\/j.mayocpiqo.2026.100695_bib14","article-title":"Increased IL-31 expression in serum and tissue protein in prurigo nodularis","volume":"13","author":"Chaowattanapanit","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"issue":"15","key":"10.1016\/j.mayocpiqo.2026.100695_bib15","article-title":"Interleukin-31 and chronic pruritus of unknown origin","volume":"15","author":"Salao","year":"2020","journal-title":"Biomark Insights"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2026.100695_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hep.32599","article-title":"IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH","volume":"77","author":"Xu","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mayocpiqo.2026.100695_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/toxins14030197","article-title":"The serum level of IL-31 in patients with chronic kidney disease-associated pruritus: what can we expect?","volume":"14","author":"\u015awierczy\u0144ska","year":"2022","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2026.100695_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2340\/00015555-0350","article-title":"Itch in primary biliary cirrhosis: a patients\u2019 perspective","volume":"88","author":"Rishe","year":"2008","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.mayocpiqo.2026.100695_bib19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/ACI.0000000000000198","article-title":"Biomarkers for atopic dermatitis: a systematic review and meta-analysis","volume":"15","author":"Thijs","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.mayocpiqo.2026.100695_bib20","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2147\/DDDT.S240866","article-title":"The efficacy and safety of abrocitinib as a treatment option for atopic dermatitis: a short report of the clinical data","volume":"15","author":"Napolitano","year":"2021","journal-title":"Drug Des Devel Ther"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2026.100695_bib21","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jaad.2018.05.1236","article-title":"Cross-sectional study of clinical distinctions between neuropathic and inflammatory pruritus","volume":"79","author":"Rosen","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2026.100695_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99249","article-title":"TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17","volume":"3","author":"Cook","year":"2018","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.mayocpiqo.2026.100695_bib23","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1172\/JCI87828","article-title":"Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation","volume":"126","author":"Achuthan","year":"2016","journal-title":"J Clin Invest"},{"issue":"880","key":"10.1016\/j.mayocpiqo.2026.100695_bib24","article-title":"CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain","volume":"880","author":"Bogacka","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"10.1016\/j.mayocpiqo.2026.100695_bib25","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s001050050651","article-title":"Der Eppendorfer Juckreizfragebogen","volume":"48","author":"Darsow","year":"1997","journal-title":"Hautarzt"},{"issue":"1","key":"10.1016\/j.mayocpiqo.2026.100695_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.mayocpiqo.2026.100695_bib27","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.jaip.2020.02.022","article-title":"Endophenotypic variations of atopic dermatitis by age, race, and ethnicity","volume":"8","author":"Nomura","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"12","key":"10.1016\/j.mayocpiqo.2026.100695_bib28","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/exd.14206","article-title":"IL-23 modulates histamine-evoked itch and responses of pruriceptors in mice","volume":"29","author":"Pavlenko","year":"2020","journal-title":"Exp Dermatol"},{"issue":"13","key":"10.1016\/j.mayocpiqo.2026.100695_bib29","article-title":"Interleukin-17 as a potential therapeutic target for chronic pain","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.mayocpiqo.2026.100695_bib30","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra2023911","article-title":"Atopic dermatitis","volume":"384","author":"St\u00e4nder","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Mayo Clinic Proceedings: Innovations, Quality &amp; Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454826000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542454826000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:51:46Z","timestamp":1781711506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542454826000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2542454826000020"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2026.100695","relation":{},"ISSN":["2542-4548"],"issn-type":[{"value":"2542-4548","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in Itch Quality Between Interleukin-31 and Thymus and Activation-Regulated Chemokine of Japanese Atopic Dermatitis","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings: Innovations, Quality & Outcomes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocpiqo.2026.100695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.","name":"copyright","label":"Copyright"}],"article-number":"100695"}}